Effects of Selenium and Exendin-4 on Glucagon-Like Peptide-1 Receptor, IRS-1, and Raf-1 in the Liver of Diabetic Rats

被引:10
作者
Barakat, Ghinwa M. [2 ]
Moustafa, Mohamed E. [1 ,2 ]
Bikhazi, Anwar B. [3 ]
机构
[1] Univ Alexandria, Dept Biochem, Fac Sci, Alexandria 21511, Egypt
[2] Beirut Arab Univ, Dept Biol & Environm Sci, Fac Sci, Beirut, Lebanon
[3] Amer Univ Beirut, Dept Physiol, Fac Med, Beirut, Lebanon
关键词
Antidiabetic; Diabetes mellitus; Exendin-4; GLP-1; receptor; Glutathione peroxidase-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; BETA-CELL; GLUCOSE; OVEREXPRESSION; STIMULATION; SUBSTRATE-1; MECHANISMS;
D O I
10.1007/s10528-012-9532-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selenium and exendin-4 exert antidiabetic effects by unknown mechanisms. Herein, we investigated their effects on the expression of glucagon-like peptide-1 receptor (GLP-1R), insulin receptor substrate-1 (IRS-1), and Raf-1 in the livers of rats with streptozotocin-induced diabetes. Diabetic rats were injected intraperitoneally with exendin-4 (0.03 mu g/kg body weight) twice daily or treated with 5 ppm selenium as sodium selenite in drinking water for 4 weeks. Both selenium and exendin-4 reduced the hyperglycemia in diabetic rats. Induction of diabetes mellitus resulted in decreased level of GLP-1R and increased levels of IRS-1 and Raf-1 in the liver. Treatment of diabetic rats with selenium or exendin-4 resulted in increased level of GLP-1R and decreased levels of IRS-1 and Raf-1 in the liver, compared with the levels in diabetic rats. Therefore, the antidiabetic actions of selenium and exendin-4 involve their effects on GLP-1R, IRS-1, and Raf-1 levels in the liver.
引用
收藏
页码:922 / 935
页数:14
相关论文
共 43 条
  • [1] Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study
    Akbaraly, Tasnime N.
    Arnaud, Josiane
    Rayman, Margaret P.
    Hininger-Favier, Isabelle
    Roussel, Anne-Marie
    Berr, Claudine
    Fontbonne, Annick
    [J]. NUTRITION & METABOLISM, 2010, 7
  • [2] Dose-Dependent Effects of Selenized Yeast on Total Selenium Levels in Prostatic Tissue of Men With Prostate Cancer
    Algotar, A. M.
    Stratton, M. S.
    Xu, M. J.
    Dalkin, B. L.
    Nagle, R. B.
    Hsu, C. H.
    Ahmann, F. R.
    Clark, L. C.
    Stratton, S. P.
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2011, 63 (01): : 1 - 5
  • [3] Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
    Ban, Kiwon
    Noyan-Ashraf, M. Hossein
    Hoefer, Judith
    Bolz, Steffen-Sebastian
    Drucker, Daniel J.
    Husain, Mansoor
    [J]. CIRCULATION, 2008, 117 (18) : 2340 - 2350
  • [4] Increased expression of insulin receptor substrate-1 in human pancreatic cancer
    Bergmann, U
    Funatomi, H
    Kornmann, M
    Beger, HG
    Korc, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) : 886 - 890
  • [5] Selenium prevents tumor development in a rat model for chemical carcinogenesis
    Björkhem-Bergman, L
    Torndal, UB
    Eken, S
    Nyström, C
    Capitanio, A
    Larsen, EH
    Björnstedt, M
    Eriksson, LC
    [J]. CARCINOGENESIS, 2005, 26 (01) : 125 - 131
  • [6] Serum selenium and diabetes in US adults
    Bleys, Joachim
    Navas-Acien, Ana
    Guallar, Eliseo
    [J]. DIABETES CARE, 2007, 30 (04) : 829 - 834
  • [7] Selenium stimulates pancreatic beta-cell gene expression and enhances islet function
    Campbell, Susan C.
    Aldibbiat, Ali
    Marriott, Claire E.
    Landy, Caroline
    Ali, Tomader
    Ferris, William F.
    Butler, Clive S.
    Shaw, James A.
    Macfarlane, Wendy M.
    [J]. FEBS LETTERS, 2008, 582 (15) : 2333 - 2337
  • [8] Douillet C, 1999, J TRACE ELEM EXP MED, V12, P379, DOI 10.1002/(SICI)1520-670X(1999)12:4<379::AID-JTRA12>3.0.CO
  • [9] 2-C
  • [10] The role of gut hormones in glucose homeostasis
    Drucker, Daniel J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01) : 24 - 32